Graham M.L. Eglit

1.1k total citations
39 papers, 581 citations indexed

About

Graham M.L. Eglit is a scholar working on Epidemiology, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Graham M.L. Eglit has authored 39 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Pharmacology and 10 papers in Experimental and Cognitive Psychology. Recurrent topics in Graham M.L. Eglit's work include Traumatic Brain Injury Research (11 papers), Cannabis and Cannabinoid Research (10 papers) and Dementia and Cognitive Impairment Research (9 papers). Graham M.L. Eglit is often cited by papers focused on Traumatic Brain Injury Research (11 papers), Cannabis and Cannabinoid Research (10 papers) and Dementia and Cognitive Impairment Research (9 papers). Graham M.L. Eglit collaborates with scholars based in United States, Australia and Russia. Graham M.L. Eglit's co-authors include Dilip V. Jeste, Barton W. Palmer, Xin Tu, Julie K. Lynch, Robert J. McCaffrey, Averria Sirkin Martin, Mark W. Bondi, Katherine J. Bangen, Alexandra J. Weigand and Amy J. Jak and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Psychopharmacology.

In The Last Decade

Graham M.L. Eglit

38 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graham M.L. Eglit United States 15 199 133 117 83 82 39 581
Yasmina Molero Sweden 16 179 0.9× 89 0.7× 302 2.6× 79 1.0× 56 0.7× 37 783
Stephen E. Hall United States 15 147 0.7× 139 1.0× 132 1.1× 64 0.8× 71 0.9× 30 856
Frieda Matthys Belgium 10 176 0.9× 89 0.7× 294 2.5× 67 0.8× 114 1.4× 46 677
Teresa Bobes-Bascarán Spain 15 273 1.4× 64 0.5× 208 1.8× 42 0.5× 48 0.6× 42 711
Baptiste Pignon France 15 299 1.5× 76 0.6× 261 2.2× 49 0.6× 60 0.7× 66 681
Qing-E Zhang Macao 12 152 0.8× 51 0.4× 123 1.1× 45 0.5× 47 0.6× 14 499
Ying‐Qiang Xiang China 16 298 1.5× 60 0.5× 220 1.9× 71 0.9× 114 1.4× 21 758
Stephen Strobbe United States 14 63 0.3× 218 1.6× 163 1.4× 85 1.0× 141 1.7× 39 758
Jan Jaracz Poland 13 232 1.2× 71 0.5× 94 0.8× 101 1.2× 85 1.0× 34 550
Bernhard T. Baune Germany 13 247 1.2× 73 0.5× 110 0.9× 54 0.7× 122 1.5× 52 787

Countries citing papers authored by Graham M.L. Eglit

Since Specialization
Citations

This map shows the geographic impact of Graham M.L. Eglit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham M.L. Eglit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham M.L. Eglit more than expected).

Fields of papers citing papers by Graham M.L. Eglit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham M.L. Eglit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham M.L. Eglit. The network helps show where Graham M.L. Eglit may publish in the future.

Co-authorship network of co-authors of Graham M.L. Eglit

This figure shows the co-authorship network connecting the top 25 collaborators of Graham M.L. Eglit. A scholar is included among the top collaborators of Graham M.L. Eglit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham M.L. Eglit. Graham M.L. Eglit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zvorsky, Ivori, et al.. (2025). A Double-Blind, Randomized, Placebo-Controlled Study Examining the Effects of CBN With and Without CBD on Sleep Quality. Drug and Alcohol Dependence. 267. 111977–111977.
2.
Kulpa, Justyna, A Harrison, Graham M.L. Eglit, et al.. (2023). Oral Cannabidiol Treatment in Two Postmenopausal Women with Osteopenia: A Case Series. Cannabis and Cannabinoid Research. 8(S1). S83–S89. 4 indexed citations
3.
Kulpa, Justyna, et al.. (2023). Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults. Cannabis and Cannabinoid Research. 9(4). e1170–e1178. 15 indexed citations
4.
Gillespie, Nathan A., Jeremy A. Elman, Ruth McKenzie, et al.. (2023). The heritability of blood‐based biomarkers related to risk of Alzheimer's disease in a population‐based sample of early old‐age men. Alzheimer s & Dementia. 20(1). 356–365. 6 indexed citations
5.
Kulpa, Justyna, Graham M.L. Eglit, Melanie L. Hill, et al.. (2022). Serum Markers of Bone Turnover Following Controlled Administration of Two Medical Cannabis Products in Healthy Adults. Cannabis and Cannabinoid Research. 9(1). 300–309. 5 indexed citations
6.
Leen‐Feldner, Ellen W., et al.. (2022). A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge. Psychopharmacology. 242(7). 1515–1527. 6 indexed citations
7.
Sanderson‐Cimino, Mark, Jeremy A. Elman, Xin Tu, et al.. (2022). Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12228–e12228. 21 indexed citations
8.
Eglit, Graham M.L., et al.. (2022). Longitudinal Relationship between the Introduction of Medicinal Cannabis and Polypharmacy: An Australian Real‐World Evidence Study. International Journal of Clinical Practice. 2022(1). 8535207–8535207. 2 indexed citations
9.
Kremen, William S., Jeremy A. Elman, Matthew S. Panizzon, et al.. (2022). Cognitive Reserve and Related Constructs: A Unified Framework Across Cognitive and Brain Dimensions of Aging. Frontiers in Aging Neuroscience. 14. 834765–834765. 28 indexed citations
10.
Peters, Erica N., et al.. (2021). Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec. Cannabis and Cannabinoid Research. 6(6). 564–572. 5 indexed citations
11.
12.
Oughli, Hanadi Ajam, Hanadi Ajam Oughli, Graham M.L. Eglit, et al.. (2020). LONELINESS, AGE, CARDIOVASCULAR AND METABOLIC HEALTH IN SCHIZOPHRENIA. American Journal of Geriatric Psychiatry. 28(4). S138–S139. 1 indexed citations
13.
Jurick, Sarah M., Laura D. Crocker, Victoria C. Merritt, et al.. (2019). Psychological Symptoms and Rates of Performance Validity Improve Following Trauma-Focused Treatment in Veterans with PTSD and History of Mild-to-Moderate TBI. Journal of the International Neuropsychological Society. 26(1). 108–118. 17 indexed citations
14.
Martin, Averria Sirkin, Graham M.L. Eglit, Rebecca Daly, et al.. (2019). Attitude Toward Own Aging Among Older Adults: Implications for Cancer Prevention. The Gerontologist. 59(Supplement_1). S38–S49. 14 indexed citations
15.
Eglit, Graham M.L., Barton W. Palmer, & Dilip V. Jeste. (2018). Overview of measurement-based positive psychiatry. Nordic Journal of Psychiatry. 72(6). 396–403. 14 indexed citations
16.
Eglit, Graham M.L., Barton W. Palmer, Averria Sirkin Martin, Xin Tu, & Dilip V. Jeste. (2018). Loneliness in schizophrenia: Construct clarification, measurement, and clinical relevance. PLoS ONE. 13(3). e0194021–e0194021. 90 indexed citations
17.
Eglit, Graham M.L., Julie K. Lynch, & Robert J. McCaffrey. (2016). Not all performance validity tests are created equal: The role of recollection and familiarity in the Test of Memory Malingering and Word Memory Test. Journal of Clinical and Experimental Neuropsychology. 39(2). 173–189. 5 indexed citations
18.
Eglit, Graham M.L., Julie K. Lynch, & Robert J. McCaffrey. (2016). Validation of Victoria Symptom Validity Test Cutoff Scores among Mild Traumatic Brain Injury Litigants Using a Known-Groups Design. Archives of Clinical Neuropsychology. 31(3). 231–245. 18 indexed citations
19.
Eglit, Graham M.L., et al.. (2015). Rates of False-Positive Classification Resulting From the Analysis of Additional Embedded Performance Validity Measures. Applied Neuropsychology Adult. 22(5). 335–347. 36 indexed citations
20.
Eglit, Graham M.L., et al.. (2013). The Degree of Conation on Neuropsychological Tests Does Not Account for Performance Invalidity among Litigants. Archives of Clinical Neuropsychology. 28(3). 213–221. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasmina Molero Breakdown of academic impact, for papers by Stephen E. Hall Breakdown of academic impact, for papers by Frieda Matthys Breakdown of academic impact, for papers by Teresa Bobes-Bascarán Breakdown of academic impact, for papers by Baptiste Pignon Breakdown of academic impact, for papers by Qing-E Zhang Breakdown of academic impact, for papers by Ying‐Qiang Xiang Breakdown of academic impact, for papers by Stephen Strobbe Breakdown of academic impact, for papers by Jan Jaracz Breakdown of academic impact, for papers by Bernhard T. Baune
Rankless by CCL
2026